European Patent Office Upholds Angiotech's Patent For Drug-Coated Stents
The European Patent Office has upheld the validity of Canadian medical device maker Angiotech Pharmaceuticals' patent on specially coated medical stents, the company said Monday....To view the full article, register now.
Already a subscriber? Click here to view full article